Jump to content

FUB-JWH-018: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
Importing Wikidata short description: "Chemical compound" (Shortdesc helper)
(15 intermediate revisions by 11 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox
{{Drugbox
| IUPAC_name = (1-(4-fluorobenzyl)-1''H''-indol-3-yl)(naphthalen-1-yl)methanone
| IUPAC_name = (1-(4-Fluorobenzyl)-1''H''-indol-3-yl)(naphthalen-1-yl)methanone
| image = FUB-JWH-018_structure.png
| image = FUB-JWH-018_structure.png
| width = 150


<!--Clinical data-->
<!--Clinical data-->
Line 9: Line 11:
| pregnancy_category =
| pregnancy_category =
| legal_AU =
| legal_AU =
| legal_CA =
| legal_CA = Schedule II
| legal_UK =
| legal_DE = NpSG
| legal_US =
| legal_UK = Class B
| legal_US = Schedule I
| legal_status =
| legal_status =
| routes_of_administration =
| routes_of_administration =
Line 23: Line 26:


<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref =
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number =
| CAS_number = 2365471-45-8
| ATC_prefix =
| ATC_prefix =
| ATC_suffix =
| ATC_suffix =
| PubChem =
| PubChem =
| ChemSpiderID =
| ChemSpiderID = 34450892
| UNII_Ref = {{fdacite|correct|FDA}}
| smiles = O=C(C1=CC=CC2=C1C=CC=C2)C3=CN(CC4=CC=C(F)C=C4)C5=CC=CC=C53
| UNII = U0Z5KO073G
| InChI =
| InChIKey =
| StdInChI = 1S/C26H18FNO/c27-20-14-12-18(13-15-20)16-28-17-24(22-9-3-4-11-25(22)28)26(29)23-10-5-7-19-6-1-2-8-21(19)23/h1-15,17H,16H2
| StdInChIKey = VREQTLWJHFQLEX-UHFFFAOYSA-N


<!--Chemical data-->
<!--Chemical data-->
| C=26 | H=18 | N=1 | O=1 | F=1
| C=26 | H=18 | N=1 | O=1 | F=1
| smiles = O=C(C1=CC=CC2=C1C=CC=C2)C3=CN(CC4=CC=C(F)C=C4)C5=CC=CC=C53
| molecular_weight = 379.43 g/mol
| StdInChI = 1S/C26H18FNO/c27-20-14-12-18(13-15-20)16-28-17-24(22-9-3-4-11-25(22)28)26(29)23-10-5-7-19-6-1-2-8-21(19)23/h1-15,17H,16H2
| StdInChIKey = VREQTLWJHFQLEX-UHFFFAOYSA-N
}}
}}


'''FUB-JWH-018''' (also known as '''FUB-018''') is an [[indole]]-based [[synthetic cannabinoid]], representing a molecular hybrid of [[JWH-018]] and [[AB-FUBICA]] or [[ADB-FUBICA]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/17332 | title=FUB-JWH 018 | publisher=Cayman Chemical | accessdate=8 July 2015}}</ref>
'''FUB-JWH-018''' (also known as '''FUB-018''') is a [[naphthoylindole]]-based [[synthetic cannabinoid]], representing a molecular hybrid of [[JWH-018]] and [[AB-FUBICA]] or [[ADB-FUBICA]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/17332 | title=FUB-JWH 018 | publisher=Cayman Chemical | access-date=8 July 2015}}</ref><ref>{{cite journal | title=Apport d'un spectromètre UHPLC-HR-Q-TOF pour l'identification des nouvelles substances psychoactives en circulation | vauthors = Lamoureux C | journal=Toxicologie Analytique et Clinique | date=June 2015 | volume=27 | issue=2 | pages=S67 | doi=10.1016/j.toxac.2015.03.107}}</ref>


==Legal Status==
==Legal status==
In the United States, all CB<sub>1</sub> receptor agonists of the 3-(1-naphthoyl)indole class such as FUB-JWH-018 are [[Schedule I Controlled Substance]]s.<ref>{{UnitedStatesCode2|21|812|Schedules of controlled substances}}</ref>


As of October 2015 FUB-JWH-018 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>
As of October 2015 FUB-JWH-018 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=zh | access-date=1 October 2015 | archive-date=1 October 2015 | archive-url=https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html | url-status=dead }}</ref>


==See also==
==See also==
Line 50: Line 53:
* [[ADB-FUBINACA]]
* [[ADB-FUBINACA]]
* [[AMB-FUBINACA]]
* [[AMB-FUBINACA]]
* [[CHM-018]]
* [[FUB-144]]
* [[FUB-144]]
* [[FUB-APINACA]]
* [[FUB-APINACA]]
* [[FUB-NNE1]]
* [[FDU-PB-22]]
* [[FDU-PB-22]]
* [[FUB-PB-22]]
* [[FUB-PB-22]]
Line 64: Line 67:
{{Cannabinoidergics}}
{{Cannabinoidergics}}



[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Designer drugs]]
[[Category:Naphthoylindoles]]
[[Category:Naphthoylindoles]]

Revision as of 10:48, 23 April 2022

FUB-JWH-018
Legal status
Legal status
Identifiers
  • (1-(4-Fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone
CAS Number
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H18FNO
Molar mass379.434 g·mol−1
3D model (JSmol)
  • O=C(C1=CC=CC2=C1C=CC=C2)C3=CN(CC4=CC=C(F)C=C4)C5=CC=CC=C53
  • InChI=1S/C26H18FNO/c27-20-14-12-18(13-15-20)16-28-17-24(22-9-3-4-11-25(22)28)26(29)23-10-5-7-19-6-1-2-8-21(19)23/h1-15,17H,16H2
  • Key:VREQTLWJHFQLEX-UHFFFAOYSA-N

FUB-JWH-018 (also known as FUB-018) is a naphthoylindole-based synthetic cannabinoid, representing a molecular hybrid of JWH-018 and AB-FUBICA or ADB-FUBICA.[1][2]

In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as FUB-JWH-018 are Schedule I Controlled Substances.[3]

As of October 2015 FUB-JWH-018 is a controlled substance in China.[4]

See also

References

  1. ^ "FUB-JWH 018". Cayman Chemical. Retrieved 8 July 2015.
  2. ^ Lamoureux C (June 2015). "Apport d'un spectromètre UHPLC-HR-Q-TOF pour l'identification des nouvelles substances psychoactives en circulation". Toxicologie Analytique et Clinique. 27 (2): S67. doi:10.1016/j.toxac.2015.03.107.
  3. ^ 21 U.S.C. § 812: Schedules of controlled substances
  4. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.